FASN and breast carcinoma: Our hypothesis was supported by previous studies, which reported that exogenous fatty acid supplementation did not prevent irreversible DNA damage and continuous apoptosis caused by cisplatin‐induced downregulation of FASN in MDA‐MB‐231 breast cancer cells.